# Fostamatinib for Treating Acute Respiratory Distress Syndrome (ARDS) in Hospitalized Adults

> **NCT06564207** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Inova Health Care Services** · enrollment: 40 (estimated)

## Conditions studied

- Acute Respiratory Distress Syndrome
- ARDS

## Interventions

- **DRUG:** Placebo
- **DRUG:** Fostamatinib

## Key facts

- **NCT ID:** NCT06564207
- **Lead sponsor:** Inova Health Care Services
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-08-30
- **Primary completion:** 2027-05-31
- **Final completion:** 2027-10-31
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2026-02-02

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06564207

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06564207, "Fostamatinib for Treating Acute Respiratory Distress Syndrome (ARDS) in Hospitalized Adults". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT06564207. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*